Article

6 Iconography
Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates



Journal of the American Academy of Dermatology
Volume 66, n° 4
pages 626-633 (avril 2012)
Doi : 10.1016/j.jaad.2011.08.031
accepted : 12 August 2011
Dermatologic Surgery

Prospective randomized controlled clinical and histopathological study of acne vulgaris treated with dual mode of quasi-long pulse and Q-switched 1064-nm Nd:YAG laser assisted with a topically applied carbon suspension
 

Jae Yoon Jung, MD a, b, Jong Soo Hong, MD a, b, Chang Ho Ahn, MD a, Ji Young Yoon, MSc b, Hyuck Hoon Kwon, MD a, b, Dae Hun Suh, MD, PhD a, b,
a Department of Dermatology, Seoul National University College of Medicine, Seoul, Korea 
b Acne Research Laboratory, Seoul National University Hospital, Seoul, Korea 

Reprint requests: Dae Hun Suh, Department of Dermatology, Seoul National University Hospital, 28 Yongon-dong, Chongno-gu, Seoul, 110-744, Korea.
Abstract
Background

Acne treatments using laser and light devices have been reported to have varying degrees of efficacy. However, there has been no study of treatment of acne using a dual mode (quasi-long pulse and Q-switched mode) 1064-nm Nd:YAG laser assisted with a topically applied carbon suspension.

Objective

To evaluate the clinical efficacy, safety, and histological changes of new laser treatment method for acne vulgaris.

Methods

Twenty-two patients received 3 sessions of quasi-long pulse and Q-switched Nd:YAG laser treatment assisted with a topically applied carbon suspension at 2-week intervals in a randomized split face manner.

Results

At the final visit, the inflammatory acne lesions were reduced on the laser-treated side by 58.6% (P  < .001), but increased on the untreated side by 5%. The noninflammatory acne lesions were reduced on the laser-treated side by 52.4% (P < .001). Sebum output reduction, inflammatory cell and cytokine reductions, a decrease of the thickness of a perifollicular stratum corneum and a full epithelium, and skin rejuvenation effect were found. The histopathologic examination of the acne lesions showed decreased inflammation and immunostaining intensity for interleukin 8, matrix metalloproteinase-9, toll-like receptor-2, and nuclear factor kappa B, and tumor necrosis factor alpha was reduced significantly. No severe adverse reactions were reported. All patients reported mild transient erythema that disappeared in a few hours.

Limitations

The number of subjects studied was small.

Conclusions

This laser treatment was rapid and effective for treating not only the inflammatory but also the noninflammatory acne lesions when compared with the control side. The histopathologic findings correlated well with the clinical acne grade and treatment response. This novel laser treatment appears to be safe and effective for acne treatment.

The full text of this article is available in PDF format.

Key words : acne, histopathologic examination, Nd:YAG laser, sebum output

Abbreviations used : H&E, HSP, IL, MMP, Nd:YAG, NF-κB, PDL, TGF-β, TLR, TNF-⍺, VAS



 Funding sources: None.
 Conflicts of interest: None declared.



© 2012  American Academy of Dermatology, Inc.@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline